Laurus Labs has entered into an agreement with Slovenia-based drug manufacturer Krka to establish a joint venture (JV) firm in Hyderabad. Under the agreement, Krka will hold a 51% stake, while Laurus Labs will hold 49%. The JV, with a registered capital equivalent to €50 million, aims to produce finished products for new markets, including India.
Disclaimer : Mymoneytimes implements extreme caution and care in collecting data before publication. Mymoneytimes does not liable for the adequacy, accuracy or completeness of any given information. Hence we are not liable for any kind of direct or indirect loss caused by the use of such information.